The Stockholm III Trial randomized patients with primary operable rectal cancers to either short-course radiotherapy ( RT ) with immediate surgery ( SRT ) , short-course RT with surgery delayed 4-8 weeks ( SRT-delay ) or long-course RT with surgery delayed 4-8 weeks .